Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Control System Improves TAVI Delivery

By HospiMedica International staff writers
Posted on 10 May 2016
An innovative transcatheter aortic valve implantation (TAVI) delivery system provides physicians with greater procedural control.

The DirecTrack Delivery System, designed for the Direct Flow Medical (Santa Rosa, CA, USA) TAVI system, is based on a flexible 18 French sheath that ensures high trackability and minimizes vascular complications. More...
The system is based on an intuitive ergonomic handle with four hollow positioning wires that allow for millimetric control and precise value positioning. The handle also includes a simple to use rotating knob for controlled unsheathing of the valve inside the left ventricle.

The valve is deployed using a standard endoflator that delivers saline pressurized to 12 atmospheres to the expanding rings through the hollow positioning wires. Following initial expansion, the valve remains fully competent throughout the procedure. Once the valve is fully deployed in the annulus, a complete assessment of hemodynamic performance can be performed. Either ring can be de-pressurized to reposition the valve by manipulating the positioning wires, which can be performed repeatedly, if necessary. All Direct Flow Medical valve sizes are implanted with the same delivery system.

When the valve is optimally placed, the saline is easily exchanged via the positioning wires for a quick-curing polymer that forms the permanent structure. During polymer transfer, pressure within the valve is constant and position of the valve is maintained. The positioning wires are then disconnected and the delivery system withdrawn. The system provides trackability in highly torturous anatomies, thanks to a unique outer sheath material that increases control of the valve during deployment. In addition, the low profile and flexible delivery system enable easy access and full visibility even in high-calcified anatomies.

“We’re pleased to provide physicians with this latest advance in TAVI procedural control,” said Dan Lemaitre, President and CEO of Direct Flow Medical. “The DirecTrack Delivery System provides all the features of our prior delivery system, but with significantly enhanced ergonomics and precision to assure the best possible clinical outcome.”

“I have had the opportunity to use every generation of the Direct Flow Medical delivery system since its inception. The new DirecTrack system is a major step forward in positioning control and smooth valve delivery,” said professor of cardiology Joachim Schofer, MD, of the Hamburg University Cardiovascular Center (Germany). “I’m impressed with the additional procedural efficiency gained, making it faster and easier to achieve an optimal outcome.”

Related Links:
Direct Flow Medical


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.